Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 83701-83750 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05515939
Evaluating the InPen in Pediatric Type 1 Diabetes
N/AActive, not recruiting
34 participants
Started: Sep 9, 2022 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT05538351
A Study to Support the Development of the Enhanced Fluid Assessment Tool for Patients With Acute Kidney Injury
N/AActive, not recruiting
120 participants
Started: Sep 9, 2022 · Completed: Aug 31, 2026
1 condition2 sponsors1 location
NCT05540340
A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant
PHASE1Recruiting
40 participants
Started: Sep 9, 2022 · Completed: Sep 30, 2026
5 conditions1 sponsor1 location
NCT05613023
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
PHASE3Recruiting
1,128 participants
Started: Sep 9, 2022 · Completed: Jun 30, 2030
1 condition2 sponsors42 locations
NCT05503862
Home Semen Testing in Men Beginning Attempts to Conceive
NAActive, not recruiting
200 participants
Started: Sep 9, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT06704230
Stress Reduction Using Video Googles on Patients Undergoing Vascular Surgery
NARecruiting
100 participants
Started: Sep 9, 2022 · Completed: Apr 30, 2025
3 conditions2 sponsors1 location
NCT05414058
Adjunctive Methylphenidate ER in Patients With Schizophrenia to Improve Functional and Cognitive Outcomes
PHASE2Recruiting
24 participants
Started: Sep 9, 2022 · Completed: Sep 9, 2025
1 condition1 sponsor1 location
NCT04931017
Metformin for Chemoprevention of Lung Cancer in Overweight or Obese Individuals at High Risk for Lung Cancer
PHASE2Active, not recruiting
50 participants
Started: Sep 9, 2022 · Completed: Jun 30, 2027
1 condition2 sponsors4 locations
NCT05691608
MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2
NARecruiting
1,800 participants
Started: Sep 9, 2022 · Completed: Sep 9, 2030
2 conditions1 sponsor29 locations
NCT05540392
An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues
PHASE1/PHASE2Active, not recruiting
60 participants
Started: Sep 9, 2022 · Completed: Sep 30, 2026
2 conditions1 sponsor8 locations
NCT05480696
Soluble Fibre Supplementation in NAFLD
PHASE2Recruiting
60 participants
Started: Sep 9, 2022 · Completed: Mar 31, 2027
3 conditions1 sponsor1 location
NCT03832127
Evaluation of PET 18F-Fludarabine for the Initial Assessment and End-treatment of Symptomatic Multiple Myeloma Patients
PHASE1Recruiting
35 participants
Started: Sep 9, 2022 · Completed: Sep 9, 2026
1 condition2 sponsors7 locations
NCT05434858
Imagery as Biomarker of Gout
NAActive, not recruiting
21 participants
Started: Sep 9, 2022 · Completed: Sep 9, 2029
1 condition2 sponsors1 location
NCT05346796
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
NARecruiting
250 participants
Started: Sep 9, 2022 · Completed: May 31, 2027
1 condition2 sponsors1 location
NCT05650307
CV Imaging of Metabolic Interventions
N/ARecruiting
150 participants
Started: Sep 9, 2022 · Completed: Sep 9, 2027
3 conditions1 sponsor1 location
NCT05654272
Development of CIRC Technologies
N/ARecruiting
1,000 participants
Started: Sep 9, 2022 · Completed: Sep 9, 2042
10 conditions1 sponsor1 location
NCT06162897
Case Management Dyad
NARecruiting
180 participants
Started: Sep 9, 2022 · Completed: Jun 30, 2027
3 conditions2 sponsors1 location
NCT05498662
An Observational Study of the T3 Pro Dental Implant System
N/ARecruiting
60 participants
Started: Sep 8, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor2 locations
NCT05437406
Family, Responsibility, Education, Support, and Health for Latino Caregivers (FRESH-LC)
NAActive, not recruiting
167 participants
Started: Sep 8, 2022 · Completed: Oct 31, 2026
2 conditions5 sponsors1 location
NCT05589376
You and Me Healthy
N/AEnrolling by invitation
20,000 participants
Started: Sep 8, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor3 locations
NCT05042375
A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer
PHASE3Recruiting
450 participants
Started: Sep 8, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor80 locations
NCT05418049
Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug Challenge
PHASE2Recruiting
45 participants
Started: Sep 8, 2022 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT05279092
Yale Steroid Enhanced Versus Exparel Nerveblock TKA RCT Study
PHASE2Recruiting
250 participants
Started: Sep 8, 2022 · Completed: Mar 31, 2028
2 conditions2 sponsors2 locations
NCT05394506
Modifying Factors in Striated Muscle Laminopathies
NARecruiting
40 participants
Started: Sep 8, 2022 · Completed: Dec 30, 2027
4 conditions1 sponsor8 locations
NCT06511856
FH ORTHO Shoulder Observatory
N/ARecruiting
500 participants
Started: Sep 8, 2022 · Completed: Sep 8, 2035
2 conditions1 sponsor3 locations
NCT05276973
Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer
PHASE1Active, not recruiting
25 participants
Started: Sep 8, 2022 · Completed: Feb 26, 2026
18 conditions2 sponsors8 locations
NCT06506084
Observational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV)
N/ARecruiting
319 participants
Started: Sep 8, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor37 locations
NCT05272423
Studying Pathways of Resistance in KRAS-driven Cancers
N/AActive, not recruiting
500 participants
Started: Sep 8, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05576948
Natural History of Cerebral Palsy Prospective Study
N/ARecruiting
100 participants
Started: Sep 8, 2022 · Completed: Sep 8, 2027
1 condition2 sponsors1 location
NCT05549713
The Effect of Upper Blepharoplasty on Vision Quality in the Early Postoperative Period
N/ARecruiting
40 participants
Started: Sep 8, 2022 · Completed: Jan 1, 2026
4 conditions1 sponsor1 location
NCT04788004
Long-term Recovery: Longitudinal Study of Neuro-behavioral Markers of Recovery and Precipitants of Relapse
N/AActive, not recruiting
733 participants
Started: Sep 8, 2022 · Completed: Jul 20, 2026
1 condition1 sponsor1 location
NCT05454839
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
N/AActive, not recruiting
1,098 participants
Started: Sep 8, 2022 · Completed: Dec 31, 2026
1 condition4 sponsors2 locations
NCT04963751
ERAS in Pediatric & Adolescent Gynecology Preoperative Counseling
NARecruiting
60 participants
Started: Sep 8, 2022 · Completed: Jun 30, 2027
2 conditions1 sponsor1 location
NCT05443451
BETTY: BEnign Prostatic Hyperplasia Transperineal Targeted Microwave therapY
NARecruiting
12 participants
Started: Sep 8, 2022 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT05347550
Examining the Benefit of Graduated Compression Stockings in the Prevention of vEnous Thromboembolism in Low-risk Surgical Patients
NARecruiting
21,472 participants
Started: Sep 8, 2022 · Completed: Dec 31, 2025
1 condition3 sponsors9 locations
NCT05553873
Evaluation of Inflammatory Markers in ph Negative Myeloproliferative Neoplasms: Impact on Outcome and Response to Therapy. Multicenter Retro-prospective Observational Study. The INFLA-ME (INFLAmmation in Myeloproliferative Disease) Study.
N/ARecruiting
500 participants
Started: Sep 8, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor11 locations
NCT05508958
Cup Revisions Through Anterior or Posterolateral Approach: an RCT
NAEnrolling by invitation
68 participants
Started: Sep 8, 2022 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT05667610
Immune-supportive Diet and Gut Permeability in Allergic Children
NARecruiting
132 participants
Started: Sep 8, 2022 · Completed: Jun 30, 2027
2 conditions11 sponsors1 location
NCT05525845
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
NARecruiting
15 participants
Started: Sep 8, 2022 · Completed: Aug 31, 2028
1 condition1 sponsor1 location
NCT05935722
Evaluation of a Home-based Parenting Support Program: Parenting Young Children
NARecruiting
60 participants
Started: Sep 8, 2022 · Completed: Jun 30, 2026
3 conditions6 sponsors5 locations
NCT05625737
Fruquintinib Combined with Sintilimab As Second-line Therapy for Gastric or Gastro-esophageal Junction Adenocarcinoma
PHASE2Active, not recruiting
29 participants
Started: Sep 8, 2022 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05528263
Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial)
NAActive, not recruiting
89 participants
Started: Sep 8, 2022 · Completed: Feb 28, 2026
6 conditions2 sponsors1 location
NCT05209074
Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic Adenocarcinoma
PHASE1Active, not recruiting
16 participants
Started: Sep 8, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05651204
GABA Biomarkers in Dravet Syndrome
N/ARecruiting
36 participants
Started: Sep 8, 2022 · Completed: Sep 8, 2027
1 condition2 sponsors1 location
NCT06342206
The Assessment of Acute /Chronic Phase in Patients With Ischemic Cerebral Stroke Using TCM Diagnostic Tools
N/ARecruiting
24 participants
Started: Sep 8, 2022 · Completed: Mar 27, 2025
1 condition1 sponsor1 location
NCT05564091
Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only in Patients With Mild to Moderate Primary Open-Angle Glaucoma
NARecruiting
78 participants
Started: Sep 8, 2022 · Completed: Jul 31, 2027
1 condition2 sponsors4 locations
NCT05551052
CRC Detection Reliable Assessment With Blood
N/AActive, not recruiting
196 participants
Started: Sep 8, 2022 · Completed: Dec 31, 2027
16 conditions1 sponsor3 locations
NCT05580315
EPOS Discoid Meniscus (DiMe) Project
N/ARecruiting
500 participants
Started: Sep 8, 2022 · Completed: Sep 1, 2042
1 condition1 sponsor12 locations
NCT05169593
Prevention of Postoperative Endoscopic Recurrence with Endoscopy-driven Versus Systematic Biological Therapy
PHASE4Recruiting
292 participants
Started: Sep 8, 2022 · Completed: Oct 31, 2030
1 condition1 sponsor28 locations
NCT05570058
Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis
PHASE2Active, not recruiting
48 participants
Started: Sep 8, 2022 · Completed: Jan 9, 2025
2 conditions2 sponsors31 locations